RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.220
-0.040 (-3.17%)
At close: Sep 17, 2025, 4:00 PM EDT
1.250
+0.030 (2.46%)
After-hours: Sep 17, 2025, 7:35 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $44.71 million as of September 17, 2025. Its market cap has increased by 80.96% in one year.
Market Cap
44.71M
Enterprise Value
33.39M
1-Year Change
80.96%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $44.71M, a decrease of -34.87%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 46.17M | 49.13% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |